Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Accelerated Approval Price Caps: Policy Has High Profile Support – But Can It Be Done?

01 Feb 2023

• By Michael McCaughan

Price cap — Questions remain about how to impose a price cap on products cleared using accelerated approval. • Source: Shutterstock

Related Content

Medicare Part D Redesign Could Expand Rebate-Driven Formulary Exclusions In Program

26 Jan 2023

Woodcock: High Prices Create Problems For Entire Accelerated Approval Program

04 Jan 2022

MedPAC’s Message To Congress: Drug Pricing Still Needs Attention

22 Sep 2022

Related Companies

Biogen, Inc.

Additional Topics

United States Pricing Debate Review Pathway Regulation Medicaid Policy BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.